Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9382231 Bipyrazole derivatives as JAK inhibitors

Patent 9382231 was granted and assigned to Incyte on July, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071439 Process and intermediates for preparing a JAK inhibitor
0
Edits on 29 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 May, 2024
Edits on 17 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11957661 JAK1 pathway inhibitors for the treatment of vitiligo
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11905292 Process and intermediates for preparing a JAK inhibitor
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11905275 Bipyrazole derivatives as JAK inhibitors
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833152 JAK1 pathway inhibitors for the treatment of cytokine-related disorders
0
Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+69 characters)
Article

Patent abstract

The present invention provides compounds of Formula I:

Edits on 29 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 29 Sep, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Ding-Quan Qian0
Jincong Zhuo0
Song Mei0
Yun-Long Li0
Edits on 21 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=09382231
Edits on 28 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11685731 Processes of preparing a JAK1 inhibitor
0
Edits on 21 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09382231 Bipyrazole derivatives as JAK inhibitors US Patent 9382231 Bipyrazole derivatives as JAK inhibitors

Infobox
Patent Number
09382231
Patent Number
9382231
Edits on 5 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 5 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09382231
Edits on 7 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09382231 Bipyrazole derivatives as JAK inhibitors

Infobox
Is a
Patent
Patent
Patent applicant
Incyte
Incyte
Current assignee
Incyte
Incyte
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09382231
Date of patent
July 5, 2016
Patent application number
14279929
Date Filed
May 16, 2014
Patent primary examiner
‌
Kamal Saeed

Find more entities like US Patent 9382231 Bipyrazole derivatives as JAK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo